
|Articles|March 31, 2008
FDA studying if gel for diabetic ulcers causes cancer
Regranex is being studied by the FDA on whether it is linked to higher rates of cancer.
Advertisement
Is Regranex (becaplermin, Johnson & Johnson) Gel, which helps heal foot and leg diabetic ulcers, associated with higher rates of cancer death? That?s what the Food & Drug Administration is now studying. In an early 
 To see more Daily News articles, 
To go to the Drug Topics homepage, 
Newsletter
Pharmacy practice is always changing. Stay ahead of the curve with the Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Drug Topics
1
Naloxone Sales Highlight Limited OTC Use, Access Challenges
2
Pharmacists Shifting from Reactive to Proactive Diabetes Counselors
3
Investigators Evaluate Decline in Percentage of Patients With COPD Using Inhaled Corticosteroids
4
Is it Safe for Birth Control Users to Go Years Without a Period?
5




















































































































































